Synopsis
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - FOR SOLUTION;INTRAVENOUS - 80MG/VIAL...DOSAGE - FOR SOLUTION;INTRAVENOUS - 80MG/VIAL;0.02MG/VIAL;0.001MG/VIAL;5MG/VIAL;0.01MG/VIAL;0.14MG/VIAL;17MG/VIAL;0.2MG/VIAL;1MG/VIAL;1.4MG/VIAL;EQ 1.2MG BASE/VIAL;0.7MG/VIAL;7MG/VIAL
USFDA APPLICATION NUMBER - 18920
DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/...DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;0.03MG/ML
USFDA APPLICATION NUMBER - 21163
DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/...DOSAGE - SOLUTION;INTRAVENOUS - 2 IU/ML;40MG/ML;12MCG/ML;40 IU/ML;1MCG/ML;3MG/ML;120MCG/ML;8MG/ML;1.2MG/ML;0.72MG/ML;1.2MG/ML;660 IU/ML;30MCG/ML
USFDA APPLICATION NUMBER - 21163
DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;...DOSAGE - INJECTABLE;INTRAVENOUS - 200MG/VIAL;0.06MG/VIAL;0.005MG/VIAL;15MG/VIAL;0.005MG/VIAL;0.6MG/VIAL;40MG/VIAL;6MG/VIAL;3.6MG/VIAL;6MG/VIAL;1MG/VIAL;10MG/VIAL;0.15MG/VIAL
USFDA APPLICATION NUMBER - 21625
DOSAGE - INJECTABLE;INJECTION - 20MG/ML;0.006...DOSAGE - INJECTABLE;INJECTION - 20MG/ML;0.006MG/ML;0.05MCG/ML;1.5MG/ML;0.0005MG/ML;0.06MG/ML;4MG/ML;0.6MG/ML;0.36MG/ML;0.6MG/ML;0.1MG/ML;1MG/ML
USFDA APPLICATION NUMBER - 8809
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kewpie Corporation
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Bioplus Life Sciences
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]BioSpectra
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Clariant
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Hayashibara
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lubrizol Life Science Health
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shandong Focus Biotechnology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shijiazhuang Huaxu Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Zhejiang Huakang Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Topical
Solubilizers
Thickeners and Stabilizers
Parenteral
Fillers, Diluents & Binders
Taste Masking
Emulsifying Agents
Film Formers & Plasticizers
Direct Compression
Coating Systems & Additives
Surfactant & Foaming Agents
Chewable & Orodispersible Aids
Co-Processed Excipients
Rheology Modifiers
Lubricants & Glidants
Granulation
Disintegrants & Superdisintegrants
Controlled & Modified Release
API Stability Enhancers
Coloring Agents
Soft Gelatin
Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
Analytical Methods
ABOUT THIS PAGE
36
PharmaCompass offers a list of D-Panthenol API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right D-Panthenol manufacturer or D-Panthenol supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred D-Panthenol manufacturer or D-Panthenol supplier.
PharmaCompass also assists you with knowing the D-Panthenol API Price utilized in the formulation of products. D-Panthenol API Price is not always fixed or binding as the D-Panthenol Price is obtained through a variety of data sources. The D-Panthenol Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol;, including repackagers and relabelers. The FDA regulates Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; supplier is an individual or a company that provides Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; active pharmaceutical ingredient (API) or Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; finished formulations upon request. The Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; suppliers may include Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; API manufacturers, exporters, distributors and traders.
click here to find a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; DMF (Drug Master File) is a document detailing the whole manufacturing process of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; active pharmaceutical ingredient (API) in detail. Different forms of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; DMFs exist exist since differing nations have different regulations, such as Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; DMF submitted to regulatory agencies in the US is known as a USDMF. Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; USDMF includes data on Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol;'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; Drug Master File in Japan (Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; JDMF) empowers Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; JDMF during the approval evaluation for pharmaceutical products. At the time of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; suppliers with JDMF on PharmaCompass.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP of the European Pharmacopoeia monograph is often referred to as a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; Certificate of Suitability (COS). The purpose of a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; to their clients by showing that a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP has been issued for it. The manufacturer submits a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP (COS) as part of the market authorization procedure, and it takes on the role of a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP holder for the record. Additionally, the data presented in the Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; DMF.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; suppliers with NDC on PharmaCompass.
Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; GMP manufacturer or Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; GMP API supplier for your needs.
A Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CoA (Certificate of Analysis) is a formal document that attests to Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol;'s compliance with Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; specifications and serves as a tool for batch-level quality control.
Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CoA mostly includes findings from lab analyses of a specific batch. For each Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; may be tested according to a variety of international standards, such as European Pharmacopoeia (Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; EP), Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Butyramide, a,g-dihydroxy-N-(3-hydroxypropyl)-b,b-dimethyl- (4CI);2,4-Dihydroxy-N-(3-hydroxypropyl)-3,3-dimethylbutyramide;DL-Panthenol;DL-Pantothenol;DL-Pantothenyl alcohol; USP).
